19333 W NORTH AVE STE 309
Ilya Petrou, MD, is a contributing writer for Dermatology Times.
October 21, 2020
A recent study showed that curettage and cryotherapy, and electrodesiccation and curettage are two techniques that have comparable cure rates. The study’s findings highlight the efficacy and reliability of these treatment approaches for minimally invasive cutaneous carcinomas.
October 11, 2020
There is a dire need to improve the clinical tools dermatologists use to assess the severity of acne scars. This 3D imaging technique may help, according to a recent study presented at the 2020 virtual American Society for Dermatologic Surgery (ASDS) meeting.
August 10, 2020
The implementation of artificial intelligence technology in the long-term management and follow-up of acne patients may help to improve patient treatment outcomes.
July 28, 2020
A topical minocycline foam application appears effective and was well-tolerated by patients with moderate-to-severe papulopustular rosacea.
July 21, 2020
A recent study aimed to elucidate the association between variations in the skin’s microbiome and the development of rosacea symptoms.
July 17, 2020
While recognizing that a patient’s mental health generally improves with isotretinoin use due to improvement in acne symptoms, clinicians may consider screening for insomnia during the course of treatment, as it may be an indicator for vulnerability to side effects, researchers say.
July 16, 2020
Many current acne clinical trials do not consider those patients already on hormone therapy, which researchers say may affect therapeutic outcomes. Authors of a recent study encourage this reporting in future studies to help clinicians better assess how the data might represent a practice population.
July 15, 2020
A novel filler injection technique may address the different facial areas and compartments as well as respect the line of ligaments for optimal lifting and volumizing effects requiring less filler product.
July 14, 2020
Treatment for Merkel cell carcinoma has evolved due to the high aggressiveness and metastatic rate of the tumors. Immune checkpoint inhibitor therapy may change prognosis and quality of life.
July 13, 2020
The biology of nonmelanoma skin cancers and their strong immunogenicity makes these tumors good candidates for novel and emerging immunotherapeutic agents.
